~ Buy the SODIUM POLYSTYRENE SULFONATE Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR SODIUM POLYSTYRENE SULFONATE

All Clinical Trials for sodium polystyrene sulfonate

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00004328 ↗	Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I	Completed	University of Texas	Phase 2	1992-12-01	OBJECTIVES: I. Establish the sodium and potassium intake that will maintain a normovolemic state in a patient with pseudohypoaldosteronism. II. Determine the effect of extracellular fluid volume and serum potassium manipulations on exercise tolerance, cardiac function, and endurance. III. Investigate pharmacologic methods of limiting excretion of sodium in urine and sweat.
NCT00004328 ↗	Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I	Completed	National Center for Research Resources (NCRR)	Phase 2	1992-12-01	OBJECTIVES: I. Establish the sodium and potassium intake that will maintain a normovolemic state in a patient with pseudohypoaldosteronism. II. Determine the effect of extracellular fluid volume and serum potassium manipulations on exercise tolerance, cardiac function, and endurance. III. Investigate pharmacologic methods of limiting excretion of sodium in urine and sweat.
NCT01189344 ↗	Levothyroxine (L-T4) Absorption After Bariatric Surgery	Completed	University of Sao Paulo	N/A	2007-09-01	Intestinal absorption of levothyroxine (LT4) tablets depends on its dissolution in gastric acid secretion, which is reduced after bariatric interventions. Impaired LT4 absorption due to low gastric dissolution has been reported in patients with atrophic or chronic gastritis. The objective of this study is to evaluate the absorption of LT4 tablets in morbidly obese patients before and after Roux-en-Y bariatric surgery.

Clinical Trial Conditions for sodium polystyrene sulfonate

Condition Name

Condition Name for sodium polystyrene sulfonate
Intervention	Trials
Hyperkalemia	3
Attention Deficit Hyperactivity Disorder	1
Chronic Kidney Failure	1

Condition MeSH

Condition MeSH for sodium polystyrene sulfonate
Intervention	Trials
Hyperkalemia	4
Obesity, Morbid	1
Pseudohypoaldosteronism	1

Clinical Trial Locations for sodium polystyrene sulfonate

Trials by Country

Trials by Country for sodium polystyrene sulfonate
Location	Trials
United States	4
Brazil	1
Canada	1

Trials by US State

Trials by US State for sodium polystyrene sulfonate
Location	Trials
Florida	2
California	1
New York	1

Clinical Trial Progress for sodium polystyrene sulfonate

Clinical Trial Phase

Clinical Trial Phase for sodium polystyrene sulfonate
Clinical Trial Phase	Trials
Phase 4	5
Phase 2	1
N/A	1

Clinical Trial Status

Clinical Trial Status for sodium polystyrene sulfonate
Clinical Trial Phase	Trials
Completed	5
Recruiting	1
Terminated	1

Clinical Trial Sponsors for sodium polystyrene sulfonate

Sponsor Name

Sponsor Name for sodium polystyrene sulfonate
Sponsor	Trials
Maisonneuve-Rosemont Hospital	1
Weill Medical College of Cornell University	1
The Rogosin Institute	1

Sponsor Type

Sponsor Type for sodium polystyrene sulfonate
Sponsor	Trials
Other	9
Industry	2
NIH	1